Electroducer logo — 
A device to secure and optimise Trans-Heart Valve Intervent...

Electroducer

A device to secure and optimise Trans-Heart Valve Interventions (THV) or Percutaneous Coronary Interventions (PCI)

Founded 2017 France France 10 employees Series A Total: $3.00M Medical Devices

General Information

Company Name Electroducer
Founded Year 2017
Location France France +1
Employees 10
Industries Medical Devices
Funding Stage Series A
Social

Get notified when Electroducer moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Electroducer

Electroducer is a French startup founded in 2017 that has introduced a revolutionary mechanical device to improve TransHeart Valve (THV) & Percutaneous Coronary Interventions (PCI) through rapid pacing using the Left Ventricular Guidewire. This innovation holds significant promise in simplifying cardiac procedures and has patents pending in addition to being classified as a Class II device. Notably, the €3.00M Series A investment in June 30, 2021 demonstrates strong investor confidence in Electroducer's potential. The pioneering device offers temporary pacing without the need for a pacemaker and can be utilized during THV (TAVI, TMVR, TTVR) and complex PCI (Rotablator, STEMI) procedures. Additionally, it seamlessly integrates with usual introducers, further enhancing its applicability. Given the significant investment support and the potential to address critical needs in cardiac interventions, Electroducer presents an exciting opportunity for venture capital firms looking to invest in impactful medical innovations.

Taxonomy: medical device, cardiac procedures, interventional cardiology, device optimization, temporary pacing, electrocardiology, innovative technology, patented device, transcatheter interventions, Class II medical device, THV, PCI, rapid pacing, left ventricular guidewire, complex PCI

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• - 30 Jun 2021

Electroducer Alternatives & Competitors

Electroducer vs

CorFlow Therapeutics creates a device for real-time MVO diagnosis and treatment in cath lab.

Series B
5 employees
Biotechnology
Electroducer vs

Dedicated to natural breathing by empowering patients to wean off mechanical ventilation and breathe...

Series Unknown
58 employees
Biotechnology, Health Care

FAQ About Electroducer

A device to secure and optimise Trans-Heart Valve Interventions (THV) or Percutaneous Coronary Interventions (PCI)
Electroducer was founded in 2017.
Electroducer is headquartered in France.
Electroducer operates in the following industries: Medical Devices.
Electroducer has approximately 10 employees.
Electroducer has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Series A.
Top alternatives and competitors to Electroducer include CorFlow Therapeutics, Lungpacer Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Electroducer and CorFlow Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Electroducer and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes